FINSBURY WORLDWIDE PHARMACEUTICAL TRUST PLC
NET ASSET VALUE
Undiluted
The estimated un-audited net asset value, calculated in accordance with the
guidelines of the Association of Investment Companies, for Finsbury Worldwide
Pharmaceutical Trust PLC at the close of business on 24 December 2009 was
670.40p (ex income) 673.84p (cum income).
Diluted
The estimated un-audited net asset value, assuming the exercise in full of all
the outstanding subscription shares at an exercise price of 614p per
subscription share at the close of business on 24 December 2009 was 660.46p (ex
income) 663.30p (cum income).
Fully Diluted
The estimated un-audited net asset value, assuming the reissue of all of the
4,556,439 shares currently held in treasury, at the closing mid-market share
price on 24 December 2009, and assuming the exercise in full of all of the
outstanding subscription shares at an exercise price of 614p per subscription
share was 655.69p (ex income) 658.31p (cum income).
For and on behalf of the Board
Frostrow Capital LLP
Secretary
29 December 2009
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.